KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Assets (2020 - 2025)

Royalty Pharma's Return on Assets history spans 6 years, with the latest figure at 0.07% for Q4 2025.

  • For Q4 2025, Return on Assets fell 1.0% year-over-year to 0.07%; the TTM value through Dec 2025 reached 0.07%, down 1.0%, while the annual FY2025 figure was 0.07%, 1.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.07% at Royalty Pharma, down from 0.07% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.12% in Q2 2021 and bottomed at 0.01% in Q4 2022.
  • The 5-year median for Return on Assets is 0.07% (2022), against an average of 0.07%.
  • The largest annual shift saw Return on Assets dropped -8bps in 2021 before it increased 9bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.07% in 2021, then tumbled by -81bps to 0.01% in 2022, then surged by 691bps to 0.11% in 2023, then crashed by -30bps to 0.07% in 2024, then decreased by -7bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for RPRX's Return on Assets are 0.07% (Q4 2025), 0.07% (Q3 2025), and 0.09% (Q2 2025).